Drug Topics
MAY 25, 2025
Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discussed his role in uncovering PBM practices and pharmacy consulting.
STAT
MAY 24, 2025
Florida has just banned fluoride in public water , becoming the second state to do so. It’s part of decadeslong battle that has heated up in recent years. Local governments debate whether it belongs in the water supply. Parents question safety. Pseudoscience clouds public perception. Often, the conversation is framed as a domestic ideological battle between personal liberty and public health mandates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 27, 2025
Roche is moving its antibiotic zosurabalpin into phase 3 for CRAB, potentially a big step forward in the fight against antimicrobial resistance
Pharmaceutical Technology
MAY 27, 2025
The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 28, 2025
Researchers conducted a scoping review to evaluate conversational AI agents and their use in pharmacy education.
STAT
MAY 28, 2025
Robert F. Kennedy Jr.’s unilateral decision that the Centers for Disease Control and Prevention would no longer recommend Covid-19 boosters for healthy people during childhood or pregnancy represents a bulldozing of safeguards intended to keep public health officials honest and their decisions transparent. It also tramples on individuals’ ability to make their own decisions about medical evidence.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 30, 2025
The FDA grants fast track designation to TEV-53408, a promising treatment for celiac disease designed to address gluten intolerance and improve patient outcomes.
Drug Topics
MAY 27, 2025
Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.
STAT
MAY 27, 2025
CAMBRIDGE, Mass. — It began, unlike any other international meeting devoted to discussions of powerful DNA-modifying technologies, with a dance. Four neon leotard-clad bodies whirled and contorted, cleaving and helixing across the stage at the American Academy of Arts and Sciences in the kinetically charged choreography of DNA strands and CRISPR enzymes caroming around a human cell.
pharmaphorum
MAY 28, 2025
InflaRx has abandoned its drug development programme, vilobelimab for rare skin disease pyoderma gangrenosum, cratering its share price.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MAY 27, 2025
Following a meeting of the Vaccines and Related Biological Products Advisory Committee, the FDA announced their recommendation of COVID-19 vaccines targeting LP.8.1, a strain of the JN.1 variant that has become dominant in the US.
Drug Topics
MAY 27, 2025
David Swenson, RPh, discussed drug shortage technology that his company is helping bring to community pharmacies across the country.
STAT
MAY 28, 2025
Strolling past the sleek, blue-lit pop-up stores and lounges that began peppering the city of Austin, Texas, this spring, passersby might pause to wonder about what trendy new tech product goes by the name of “IQOS.” Perhaps a smartwatch or a set of noise-canceling wireless earbuds? The chicly futuristic branding of IQOS, a heated tobacco product owned by Philip Morris International, is one of several things worrying researchers and anti-tobacco advocates.
PharmaVoice
MAY 30, 2025
An oncology pivot recently paid off for the large pharma, which scored a milestone nod for its lead ADC.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 28, 2025
Pre-treatment DPYD genotyping significantly reduces hospitalizations and costs for patients with cancer, enhancing safety and efficiency in oncology care.
Drug Topics
MAY 27, 2025
Researchers explored how relationships between physicians, pharmacists, and patients are associated with the use of generic drugs in Japanese pharmacies.
STAT
MAY 29, 2025
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. NIH is terminating research grants left and right, impeding early career paths and leading some young scientists to consider becoming plumbers.
pharmaphorum
MAY 27, 2025
For the second year running, data at ASCO on Merus' bispecific antibody petosemtamab in head and neck cancer has drawn the eye
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MAY 28, 2025
Derek Webb, PharmD, a community pharmacist and Virginia Board of Pharmacy member, provides comprehensive guidance on managing seasonal allergies, distinguishing between symptoms, and exploring treatment options for patients.
Drug Topics
MAY 24, 2025
Triptans are often a first-line treatment for migraine and can be used to treat menstrual migraine and cluster headaches.
STAT
MAY 27, 2025
Mickey Mouse wishes he had the profit margins of some hospitals. AdventHealth is currently more profitable than the average company within the S&P 500. The tax-exempt, religious system, which runs 53 hospitals across nine states, generated a 17% operating margin and 23% net margin, inclusive of investments, in the first three months of 2025. Its net margin was larger than that of Amazon, ExxonMobil, and, yes, Walt Disney.
Pharmafile
MAY 28, 2025
Milan, 27 May 2025 A researcher from the Wellcome Sanger Institute near Cambridge has been awarded a prestigious international Fellowship by the IBSA Foundation for scientific research, recognising her groundbreaking work on skin cell biology. Dr Masami Ando Kuri, originally from Mexico, is one of six global winners of the 2024 IBSA Foundation Fellowships, […] The post UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study appeared first on Pharmafile.
Pharmacy Times
MAY 27, 2025
In this roundtable, 3 pharmacy faculty members reflect on how shifting federal priorities and the defunding of research initiatives have impacted their work, communities, and careerswhile highlighting the power of resilience, solidarity, and reimagined academic impact in advancing public health equity.
Drug Topics
MAY 29, 2025
The data show a decrease in all-cause mortality for sustained midlife weight loss achieved without surgical or pharmacological interventions.
STAT
MAY 27, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning, I hope you had a nice long weekend. I spent it working on my first (baby-sized) quilt, playing soccer, and eating lots of good food. But now it’s back to the news.
The Checkup by Singlecare
MAY 28, 2025
Adderall is a brand-name prescription drug best known for treating attention deficit hyperactivity disorder (ADHD). However, Adderall and its generic version (the active ingredients amphetamine and dextroamphetamine) are also FDA-approved for the treatment of narcolepsy. Both brand-name and generic Adderall are also available in immediate-release (IR) and extended-release (ER) forms.
Pharmacy Times
MAY 28, 2025
Grace Nguyen, PharmD, BCPS, provides real-world experiences with DPYD genotype-guided fluoropyrimidine dosing, highlighting how pharmacist-led interventions and tailored dose adjustments can help mitigate toxicity risks and optimize treatment in variant carriers.
Drug Topics
MAY 28, 2025
Micah Cost, PharmD, MS, CAE, discusses the biggest issues currently impacting the pharmacy profession.
STAT
MAY 27, 2025
It’s easy to feel as though you’re doing something wrong these days if you don’t know your VO 2 -Max and how many hours of REM sleep you get each night, or if you’re not taking a dozen different supplements and scrutinizing every morsel of food that makes its way into your mouth. “Biohackers” and other longevity seekers — with their many podcasts, YouTube channels, and X accounts — would have you believe that if you diligently measure your
pharmaphorum
MAY 29, 2025
Pfizer has been found to be in breach of the UK pharma industry's code of practice with posts on Twitter (now X), dating back to 2020
Pharmacy Times
MAY 28, 2025
Integrated health system specialty pharmacies can improve patient care for nonmultiple sclerosis neurologic conditions.
Drug Topics
MAY 29, 2025
The replacement therapy is indicated for patients 5 years and older, marking the first approval for an oral solution form of hydrocortisone.
STAT
MAY 29, 2025
For the past decade, Stealth BioTherapeutics has ridden a rollercoaster trying to convince the Food and Drug Administration to approve its ultra-rare disease drug. Now, the company has encountered yet another twist — an unexpected regulatory rejection that will not only delay access and strain its finances, but ensure some of the most vulnerable patients are denied the treatment.
Expert insights. Personalized for you.
590 
Let's personalize your content